The future of serialisation software is modular and scalable: part 2

Published: 10-Nov-2017

Worldwide, the regulations governing the serialisation of medicines are becoming more complex and extensive

You need to be a subscriber to read this article.
Click here to find out more.

Many countries prescribe both serialisation and the aggregation of secondary packaging into packaging hierarchies to allow the seamless tracking of medicines throughout the entire logistics chain — thus accomplishing end-to-end track and trace capability. This entails comparing the previously serialised individual packs with the serialisation database during the manual or mechanised packaging process to produce what are known as parent-child relationships (Figure 3).

In the case of packaging by machine, defective and illegible packs can repeatedly impede successful aggregation and will need to be exchanged manually at the end of the process. If necessary, the serialisation software must also be able to model these operations at Level 3. At the very latest, for the purposes of repackaging and order picking in the warehouse, it should be possible to partially dissolve or redefine the originally established child-parent relationships. For users who already, or may in the future, export to countries where a track and trace capability is mandatory, it is essential that the software and database solution accommodates these aspects. Such a requirement already exists in Turkey and is scheduled for implementation in the USA. Protocols such as EPCIS from GS1 seem to be a good standard for information interchange within the logistics chain. A suitable software solution should be prepared for that.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like